10x Genomics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $642.8 | $610.8 | $618.7 | $516.4 | $490.5 |
| Operating income | -$61.0 | -$194.6 | -$265.3 | -$167.9 | -$52.3 |
| Net income | -$43.5 | -$182.6 | -$255.1 | -$166.0 | -$58.2 |
| Cash Flow Statement | |||||
| Free cash flow | $130.1 | -$5.7 | -$63.8 | -$165.3 | -$122.7 |
Shares outstanding 130.3M · Free float 84.6%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.